Results 1 to 10 of about 38,675 (255)
Extraintestinal Clostridioides difficile infection
IDCases, 2020 Clostridioides (Clostridium) difficile is the major cause of healthcare antibiotic-associated diarrhoea. However, extra-intestinal manifestations of Clostridioides (Clostridium) difficile infection (CDI) (including bacteremia and tissue infection) are ...
Zhao Hai +6 more
doaj +3 more sources
One Swallow Does Not Make a Summer: A Confirmed Case of Imported <i>Vibrio cholerae</i> After <i>Clostridioides difficile</i> Diagnosis in Brescia, Northern Italy. [PDF]
Case Rep Infect DisVibrio cholerae, the aetiological agent of cholera, is predominantly an imported pathogen in high‐income countries. We report a case of a 49‐year‐old Nigerian male returning from Africa with abdominal pain and watery diarrhea, who rapidly developed acute kidney injury.
Seguiti C +13 more
europepmc +2 more sources
Current and future approaches in Clostridioides Difficile management [PDF]
Romanian Journal of Infectious Diseases, 2022 Clostridioides Difficile is considered one of the main causes of the healthcare associated infections worldwide and the main cause of antibiotic-associated diarrhea, with forms of clinical disease ranging from mild to deadly.
George Sebastian Gherlan
doaj +1 more source
Infective Endocarditis by Clostridioides and Clostridium Species—A Narrative Review
Antibiotics, 2023 Bacteria of the genus Clostridium are anaerobic Gram-positive spore-forming bacilli that include more than 200 species. Some of them are known to cause invasive infections and diseases caused by the production of toxins.
Petros Ioannou +4 more
doaj +1 more source
International Journal of Medical Microbiology, 2021 Clostridioides difficile is a Gram positive spore-forming rod and mainly responsible for nosocomial diarrhea in developed nations. Molecular and antimicrobial surveillance is important for monitoring the strain composition including genotypes of high ...
Ahmed Mohamed Mostafa Abdrabou +9 more
doaj +1 more source
Frontiers in Microbiology, 2022 The immunological response against Clostridioides difficile (C. difficile) is crucial for an improved understanding of disease mechanisms and the development of novel therapeutic strategies.
Sophie Roth +10 more
doaj +1 more source
Clostridioides difficile [PDF]
Trends in Microbiology, 2018 Clostridioides difficile is a spore-forming, anaerobic, intestinal pathogen that causes severe diarrhea that can lead to death. In 2011, C. difficile infected ∼500000 people in the USA and killed ∼29000 people. C. difficile infection (CDI) is the most common healthcare-related infection in the USA, leading to increased healthcare costs of $4.8 billion.
Brindar K, Sandhu, Shonna M, McBride
openaire +2 more sources
Frontiers in Immunology, 2021 BackgroundClostridioides difficile is a major cause of healthcare-associated and community-acquired diarrhea. Host genetic susceptibility to Clostridioides difficile infection has not been studied on a large-scale.MethodsA total of 1,160 Clostridioides ...
Jiang Li +11 more
doaj +1 more source
International Journal of Infectious Diseases, 2022 Recently, the recommendations for the treatment of Clostridioides difficile infection (CDI) have been updated. However, in addition to the clinical efficacy data, the drug of choice should ideally represent optimal antimicrobial stewardship, with an ...
Marcela Krutova, Mark Wilcox, Ed Kuijper
doaj +1 more source
Non–C. difficile Clostridioides Bacteremia in Intensive Care Patients, France
Emerging Infectious Diseases, 2021 Usually responsible for soft tissue infections, Clostridioides species can also cause bacteremia, life-threatening infections often requiring intensive care unit (ICU) admission.
Guillaume Morel +21 more
doaj +1 more source